⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3144798 | 1.00 | — | — | |
| SCHEMBL10054177 | 1.00 | — | — | |
| SCHEMBL13408037 | 0.80 | — | — | |
| SCHEMBL16937292 | 0.80 | — | — | |
| SCHEMBL16940981 | 0.80 | — | — | |
| SCHEMBL3278435 | 0.79 | — | — | |
| SCHEMBL5834728 | 0.79 | — | — | |
| SCHEMBL690353 | 0.79 | — | — | |
| SCHEMBL690239 | 0.79 | — | — | |
| SCHEMBL3278433 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3130586-B1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | CJ CHEILJEDANG CORP (KR) | 2019-10-23 | — | — | EP | claimed |
| US-10100026-B2 | Process for treating homoserine-based compound | CJ CHEILJEDANG CORPORATION (KR) | 2018-10-16 | — | — | US | claimed |
| EP-3130586-A1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | Cj Cheiljedang Corporation (KR) | 2017-02-15 | — | — | EP | claimed |
| US-20170037019-A1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | CJ CHEILJEDANG CORPORATION (KR) | 2017-02-09 | — | — | US | claimed |
| EP-2892870-A1 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF | Micromidas, Inc. (US) | 2015-07-15 | — | — | EP | claimed |
| US-20150148560-A1 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF | MICROMIDAS, INC. (US) | 2015-05-28 | — | — | US | claimed |
| WO-2013181604-A1 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF | MICROMIDAS, INC. (US) | 2013-12-05 | — | — | WO | claimed |
| EP-3130586-B1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | CJ CHEILJEDANG CORP (KR) | 2019-10-23 | — | — | EP | disclosed |
| US-10100026-B2 | Process for treating homoserine-based compound | CJ CHEILJEDANG CORPORATION (KR) | 2018-10-16 | — | — | US | disclosed |
| US-9688603-B2 | Polyhydroxyalkanoate derivatives, preparation and uses thereof | MICROMIDAS, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| US-9656963-B2 | Dihydropyrazole GPR40 modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170096385-A1 | POLYHYDROXYALKANOATE DERIVATIVES, PREPARATION AND USES THEREOF | MICROMIDAS, INC. (US) | 2017-04-06 | — | — | US | disclosed |
| EP-3130586-A1 | PROCESS FOR TREATING HOMOSERINE-BASED COMPOUND | Cj Cheiljedang Corporation (KR) | 2017-02-15 | — | — | EP | disclosed |
| EP-0239309-B1 | Oxadiazoles useful in the treatment of senile dementia | MERCK SHARP & DOHME (GB) | 1994-01-12 | — | — | EP | disclosed |
| EP-0548639-A2 | Polyacetals based on vinylethers and dihydroxy compounds and their use in detergent compositions | BASF Aktiengesellschaft (DE) | 1993-06-30 | — | — | EP | disclosed |
| EP-0225347-B1 | POLYESTER YARN AND METHOD FOR PREPARING IT | RHONE-POULENC VISCOSUISSE SA (CH) | 1992-08-26 | — | — | EP | disclosed |
| US-5045260-A | Dimensional stability, shrink-resistance, melt spinning, units of ethylene terephthalate and linear difunctional comonomers | RHONE-POULENC VISCOSUISSE SA (CH) | 1991-09-03 | — | — | US | disclosed |
| CN-87102972-A | Treatment senile dementia oxadiazoles useful | — | 1987-11-18 | — | — | CN | disclosed |
| EP-0225347-A1 | POLYESTER YARN AND METHOD FOR PREPARING IT. | SCHWEIZERISCHE VISCOSE (CH) | 1987-06-16 | — | — | EP | disclosed |
| WO-1986007616-A1 | METHOD FOR PREPARING MODIFIED POLYESTER YARNS AND POLYESTER YARN OBTAINED THEREBY | VISCOSUISSE SA (CH) | 1986-12-31 | — | — | WO | disclosed |